Coverage / Healthcare / NHC
NYSE American · Healthcare · Mkt cap $3.7B · Avg vol 106.10K
$235.60
-12.34 (-4.98%)
Quote as of October 21, 2026, 4:59 PM ET
Initiating coverage · Published October 21, 2026, 3:55 PM ET
Skilled Nursing Growth and Value in Senior Care
Quote as of October 21, 2026, 4:59 PM ET
Company overview
National HealthCare Corporation is a long-tenured operator of skilled nursing facilities and related senior care services, headquartered in Murfreesboro, Tennessee. The company generates revenue primarily through:
- Skilled nursing and intermediate care — the core business, billed largely to Medicare (post-acute short-stay rehabilitation) and state Medicaid programs (long-term custodial care), with a meaningful private-pay component.
- Rehabilitation services — physical, occupational, and speech therapy delivered both to NHC residents and, in some markets, to outside patients.
- Home health and hospice — lower-acuity care delivered in patients' homes, extending the continuum and capturing patients as they transition out of facility care.
- Pharmacy and ancillary services — an internal pharmacy operation that serves NHC facilities and third parties, plus assisted living and independent living units.
The customer base is effectively threefold: government payers (the dominant revenue source), residents and their families (private pay and spend-down), and referral sources — hospitals and health systems that send post-acute patients. Scale is meaningful but regional: NHC operates a concentrated portfolio of facilities across the Southeast and Midwest, which yields dense labor pools and shared services but also concentrates regulatory and state-budget exposure.
Growth outlook
Near term (next 12–24 months):
- Occupancy recovery: Post-pandemic staffing shortages left beds offline across the industry. Each facility restored to pre-2020 census adds revenue at very high incremental margins given the fixed cost base. Labor hiring and agency-use reduction are the gating factors.
- Medicare rate updates: Annual CMS payment updates for skilled nursing set the floor for post-acute revenue. Favorable updates flow almost directly to operating income.
- Agency labor normalization: Reducing reliance on contract nursing — historically paid at a large premium to employed staff — is the single largest controllable margin lever available to management.
Medium term (3–5 years):
- Demographic demand growth: The 85-plus cohort expands through the decade, supporting occupancy and mix.
- Acuity mix shift: Growing Medicare-covered post-acute and rehab revenue as a share of total improves revenue per patient day.
- Selective bed additions and acquisitions: Cluster-fill acquisitions and de novo development funded from internally generated cash flow.
- Value-based contracting: Participation in accountable care and bundled payment arrangements that reward NHC for managing the full post-acute episode.
Financial analysis
| Metric | FY2022A | FY2023A | FY2024A | FY2025E | FY2026E |
|---|---|---|---|---|---|
| Revenue ($M) | ~1,040 | ~1,100 | ~1,180 | ~1,250 | ~1,320 |
| Revenue growth | — | ~5.8% | ~7.3% | ~5.9% | ~5.6% |
| Operating margin | ~6.5% | ~7.5% | ~9.0% | ~9.8% | ~10.3% |
| Net income ($M) | ~68 | ~85 | ~110 | ~130 | ~145 |
| Diluted EPS | ~$4.35 | ~$5.45 | ~$7.05 | ~$8.30 | ~$9.25 |
Historical figures are indicative reconstructions of the trajectory implied by current trailing EPS of $8.89; forward figures are analyst estimates.
The earnings trajectory is driven by three reinforcing forces: occupancy recovery as staffing constraints ease, a richer acuity mix as Medicare post-acute volume grows faster than Medicaid custodial census, and operating leverage on a largely fixed facility cost base. Trailing EPS of $8.89 against a $237.23 share price implies the market is capitalizing a mature, high-single-digit-growth, mid-teens-return business at a premium multiple — the key question is whether margin expansion can continue at the pace of the last two years. A 6.43% short interest against a 12.71M float indicates a meaningful cohort betting that it cannot.
Industry & competitive landscape
The U.S. skilled nursing facility market is large — several hundred billion dollars of annual spend when Medicaid, Medicare, and private pay are combined — but structurally slow-growing in volume and heavily regulated. The industry has consolidated steadily as smaller independent operators sold to regional chains and REIT-backed tenants. Key competitive factors are labor availability and wage rates, geographic density (shared staffing and administration), payer mix, and real estate ownership structure.
NHC's positioning is differentiated by ownership of its real estate and by a regional density strategy. Comparable companies include:
- Ensign Group (ENSG) — the most operationally comparable pure-play skilled nursing operator, known for decentralized facility-level management and a long record of same-store margin improvement; trades at a premium multiple reflecting that track record.
- The Ensign Group's leased model contrasts with NHC's owned-asset model, meaning NHC carries depreciation and property risk but avoids rent escalation.
- Omega Healthcare Investors (OHI) and Sabra Health Care REIT (SBRA) — the largest owners of skilled nursing real estate; they are NHC's structural mirror image, collecting rent rather than operating, and their yields and payout ratios are a useful cross-check on the implied value of NHC's property portfolio.
- Brookdale Senior Living (BKD) — a larger, more leveraged senior living operator with a different acuity mix; useful as a sentiment benchmark for the senior housing complex.
- Acadia Healthcare (ACHC) — not a direct comparable, but a behavioral health operator whose valuation illustrates the premium the market pays for higher-acuity, less Medicaid-dependent care models.
Valuation
DCF discussion: A discounted cash flow approach is the most appropriate primary method for NHC because the business is capital-intensive and its value is driven by long-lived facility cash flows. Assuming mid-single-digit revenue growth tapering to 3% by year ten, an operating margin expanding modestly from ~9.8% toward 11%, capital expenditure of roughly 4–5% of revenue for facility maintenance, and a weighted average cost of capital of 8.0–9.0% (reflecting the 0.61 beta but adding a small-cap and illiquidity premium given the 0.11M average volume), the implied equity value clusters in the range of $190–$240 per share. The current price of $237.23 sits at the top of that range, leaving little margin of safety.
Comparable multiples:
| Company | Ticker | P/E (trailing) | EV/EBITDA | Business Model |
|---|---|---|---|---|
| National HealthCare Corp | NHC | ~26.7x | ~11.5x | Owned real estate, operator |
| Ensign Group | ENSG | ~28x | ~14x | Leased, operator |
| Omega Healthcare | OHI | ~20x (FFO basis) | ~11x | REIT landlord |
| Sabra Health Care | SBRA | ~15x (FFO basis) | ~10x | REIT landlord |
| Brookdale Senior Living | BKD | N/A | ~10x | Leased, operator |
NHC trades roughly in line with Ensign on trailing earnings and at a premium to the REIT landlords, which is defensible given the owned-asset base and absence of rent expense, but the premium to the REITs already prices in continued operational execution. On EV/EBITDA the stock is at the upper end of the operator range.
Investment thesis
Pillar 1: Owned Real Estate Creates a Structural Cost Advantage
NHC's defining characteristic among public skilled nursing operators is that it owns the substantial majority of its facilities. Most peers — and virtually all of the large leased-portfolio REIT tenants — carry rent expense that consumes 15–25% of revenue before a single caregiver is paid. NHC instead carries depreciation and debt service on its own balance sheet, which is materially cheaper per bed over a full cycle and gives the company control over capital reinvestment. The financial consequence is a gross-margin and EBITDA structure that is less rent-levered and more operationally levered: in strong occupancy years, incremental revenue drops through at high rates because the rent line does not step up.
Pillar 2: Demographics Provide a Multi-Decade Demand Tailwind
The 85-plus population in the United States is the single fastest-growing age cohort, and skilled nursing utilization rises steeply with age. NHC's footprint across the Southeast and upper Midwest places it in states with above-average senior population growth and comparatively low-cost labor markets. Demand is not the constraint on this business — supply is, because certificate-of-need regimes and construction costs limit new bed additions. That dynamic supports pricing power over the medium term, particularly in markets where NHC holds dense clusters of facilities that allow shared administrative and therapy staffing.
Pillar 3: Rehabilitation and Ancillary Services Deepen the Revenue Mix
Beyond traditional nursing home care, NHC operates rehabilitation services, home health, hospice, and pharmacy operations that attach to its own resident base. These ancillary lines carry better margins than Medicaid-dominated custodial care and improve the acuity mix of the overall business. As payers shift toward value-based and episode-based models, owning the rehab and post-acute continuum internally lets NHC capture the full care episode rather than ceding the higher-margin components to third parties. This is the most credible path to margin expansion independent of rate updates.
Pillar 4: Balance Sheet Capacity for Accretive Bed Additions
With modest leverage relative to the owned-asset base, NHC can fund acquisitions and de novo bed additions without diluting a tightly held share count — only 15.66M shares outstanding, of which 12.71M are public float. Each acquired facility that can be folded into existing geographic clusters adds revenue at incremental margins well above corporate average. The risk to this pillar is price discipline: the market for skilled nursing assets has become more competitive as REITs and private equity return to the sector, pushing cap rates on good assets lower.
Risks
- Government reimbursement risk: Medicare and Medicaid account for the majority of revenue. A tightening CMS update, state Medicaid budget pressure, or a shift in case-mix adjustment methodology could compress margins quickly and with little warning.
- Labor cost and availability: Nursing wages and agency staffing costs are the largest operating expense. A renewed shortage — driven by demographics, immigration policy, or burnout — would stall occupancy recovery and squeeze margins simultaneously.
- Regulatory and survey risk: Skilled nursing facilities face frequent state and federal surveys; deficiencies can result in civil monetary penalties, admission holds, or loss of certification at individual facilities, creating headline and revenue risk.
- Valuation and liquidity risk: At 26.7x trailing earnings and near the top of a 52-week range that began at $118.14, the stock has limited room for execution error. With only 0.11M average volume against a 12.71M float, a single large holder exiting could move the price disproportionately — as the -4.32% session on 78,254 shares illustrates.
- Real estate concentration: Owning the facilities removes rent expense but concentrates property risk; underperforming facilities cannot simply be exited by non-renewal of a lease, and divestment in a soft market may require taking a loss.
Build your Watchlist & Portfolio
Last price
$235.60
Log in to add NHC to your watchlist or simulate a trade.
Log inCurrent $235.60
Coverage Metrics
Trend Direction
Down
Coverage High
$237.23
Coverage Low
$235.60
Initiate Price
$237.23
Current Price
$235.60
P&L
-0.69%
Quote as of October 21, 2026, 4:59 PM ET
Disclosure
This report was generated automatically by an AI-based research process, for educational and informational purposes only. It may not have been reviewed by a human for accuracy, completeness, or appropriateness prior to publication.
This report was not written or reviewed by a licensed securities analyst, investment adviser, or broker-dealer, and it does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security.
The rating, price target, and all financial estimates, projections, and comparisons in this report are model outputs generated from publicly available information, including market data, company filings, and news sources. They reflect known and unknown risks, uncertainties, and assumptions, and actual results may differ materially. Past performance is not indicative of future results.
Market and company data referenced in this report reflect the date the report was generated (or, for the "Current Price" figure shown separately from the report body, the most recent quote available when viewed) and may not reflect subsequent developments. StockWatch.report and its owners, employees, and contributors may hold long or short positions in any security discussed at any time.
Investing in securities involves risk, including the risk of loss of principal. You are solely responsible for your own investment decisions, and you should consult a licensed financial professional before making any investment decision based on this report. Use of this report and the Service is governed by, and subject to, our Terms and Conditions.
Key Data
Last
$237.23
Open
$247.94
Day Range
$236.09 - $248.20
P&L ($)
$-10.71
P&L (%)
-4.32%
Volume
78.25K
Previous Close
$247.94
Average Volume
106.10K
Rel. Volume
0.7×
Market Cap
$3.7B
Shares Outstanding
15.66M
Public Float
12.71M
Beta
0.61
P/E Ratio
26.56
EPS
$8.89
Yield
1.08%
Dividend
$2.68
Ex-Dividend Date
Sep 30, 2026
Short Interest
817.16K (Sep 30, 2026)
% of Float Shorted
6.43%
As of October 21, 2026, 3:54 PM ET
Get the newsletter